These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1219667)

  • 21. [Efficacy and safety of dexfenfluramine treatment in obese adolescents].
    Małecka-Tendera E; Koehler B; Muchacka M; Wazowski R; Trzciakowska A
    Pediatr Pol; 1996 May; 71(5):431-6. PubMed ID: 8710426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged weight loss with dexfenfluramine treatment in obese patients.
    Finer N; Craddock D; Lavielle R; Keen H
    Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.
    Enzi G; Crepaldi G; Inelmen EM; Bruni R; Baggio B
    Clin Neuropharmacol; 1988; 11 Suppl 1():S173-8. PubMed ID: 3052815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biochemical studies on obese subjects using fenfluramine.
    Abdel-Kader MM; Mashaly M; Abdel-Aziz MT
    J Egypt Med Assoc; 1974; 57(9-10):433-41. PubMed ID: 4452780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influence of fenfluramine on the weekly curve of weight loss during obesity].
    Cabezas Cerrato J; Gómez Pérez M; Marco-Mur AL; Camarero E; Fernández-Cruz A
    Rev Clin Esp; 1974 Jan; 132(1):47-52. PubMed ID: 4840227
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatometric and hormonal effects of dexfenfluramine.
    Sonka J; Marek J; Svacina S; Sucharda P; Stĕpán J
    Sb Lek; 1995; 96(4):299-301. PubMed ID: 8711372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women.
    Rosado EL; Bressan J; Martins MF; Cecon PR; Martínez JA
    Appetite; 2007 Nov; 49(3):635-43. PubMed ID: 17658197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
    Khan M; Lum CT; Rao V
    Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
    [No Abstract]   [Full Text] [Related]  

  • 29. [Regulation of food intake and the treatment of obesity using centrally-active serotonergic drugs].
    Pijl H; Koppeschaar HP; Zelissen PM; Meinders AE
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):700-3. PubMed ID: 2038393
    [No Abstract]   [Full Text] [Related]  

  • 30. [Glucose tolerance, insulin and lipids in adipose patients following one week of fenfluramine administration].
    Schwandt P; Weisweiler P
    Verh Dtsch Ges Inn Med; 1975; 81():1473-5. PubMed ID: 1227001
    [No Abstract]   [Full Text] [Related]  

  • 31. Medicinal strategies in the treatment of obesity.
    Bray GA; Tartaglia LA
    Nature; 2000 Apr; 404(6778):672-7. PubMed ID: 10766254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.
    Monteleone P; Fabrazzo M; Tortorella A; Martiadis V; Serritella C; Maj M
    Psychoneuroendocrinology; 2005 Apr; 30(3):243-50. PubMed ID: 15511598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
    Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
    Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ephedrine, a thermogenic and potential slimming drug.
    Massoudi M; Miller DS
    Proc Nutr Soc; 1977 Dec; 36(3):135A. PubMed ID: 601014
    [No Abstract]   [Full Text] [Related]  

  • 35. Drugs regulating food intake and energy balance. Proceedings of an international symposium. Rome, September 22-25, 1986.
    Int J Obes; 1987; 11 Suppl 3():1-232. PubMed ID: 3440684
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of dexfenfluramine in the regulation of energy balance. Introduction.
    VanItallie TB
    Metabolism; 1995 Feb; 44(2 Suppl 2):1-3. PubMed ID: 7869928
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Treating the obese sportsman.
    Rathgeber R
    S Afr Med J; 1974 Oct; 48(51):2128. PubMed ID: 4428293
    [No Abstract]   [Full Text] [Related]  

  • 38. The Role of Dexfenfluramine in the Regulation of Energy Balance. Proceedings of a satellite symposium of the European Congress on Obesity. Ulm, Germany, June 10, 1993.
    Metabolism; 1995 Feb; 44(2 Suppl 2):1-61. PubMed ID: 7869929
    [No Abstract]   [Full Text] [Related]  

  • 39. A study of the energy and biochemical status of obese and non-obese students treated with 780SE.
    Miller DS; Evans E; Samuel P; Burland WL
    Postgrad Med J; 1975; 51 Suppl 1():117-20. PubMed ID: 1219667
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological effects of 780SE (992) on hyperlipidaemic and obese rats.
    Duhault J; Boulander M; Beregi L
    Postgrad Med J; 1975; 51 Suppl 1():99-104. PubMed ID: 1219688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.